Keyphrases
Novel Therapeutics
100%
Tumor
100%
Mucin 1 (MUC1)
100%
Therapeutic Vaccine
100%
MHC Binding
100%
MHC Class I
18%
Cytotoxicity
12%
Epitope
12%
Cancer Patients
12%
T Cells
12%
CD4+
12%
Tumor Antigen
12%
Transgenic Mice
6%
Vaccination
6%
Patient Demographics
6%
Specific Response
6%
Nave
6%
Signal Peptide
6%
In Silico
6%
Human Tumors
6%
Granulocyte Colony-stimulating Factor (G-CSF)
6%
Tumor-specific
6%
Balb C Mice
6%
Interferon-γ
6%
Mammary Tumor Cells
6%
Interleukin-2
6%
Prolonged Survival
6%
Cancer Vaccine
6%
CD8+
6%
CD8+ T Cells
6%
Vaccine Types
6%
Antitumor Properties
6%
Tumor Cell Lines
6%
Murine Tumors
6%
Syngeneic Mice
6%
HLA-A2
6%
Caucasian Population
6%
CD45RO
6%
Stimulation Index
6%
Non-solid Tumor
6%
Class II Alleles
6%
Memory Markers
6%
Class I Alleles
6%
L-peptide
6%
MHC Class II Alleles
6%
Synthetic Peptide Vaccine
6%
Immunology and Microbiology
MUC1
100%
Allele
18%
MHC Class I
18%
Epitope
12%
Cytotoxicity
12%
T Cell
12%
Peripheral Blood Lymphocyte
12%
Tumor Antigen
12%
Peptides
12%
CD4
6%
MHC Class II
6%
Cell Population
6%
Tumor Cell
6%
T-Helper Cell
6%
Granulocyte Macrophage Colony-Stimulating Factor
6%
Syngenic
6%
Bagg Albino Mouse
6%
CD8
6%
Cytotoxic T-Cell
6%
Immunotherapy
6%
Transgenic Mouse
6%
Interleukin 2
6%
Tumor Cell Line
6%
Tumor Vaccine
6%
Peptide Vaccine
6%
Protein Tertiary Structure
6%